AXIN2 (Axis Inhibition Protein 2), also known as Conductin or Axil, is a close homolog of AXIN1 that serves as a scaffold protein in the beta-catenin destruction complex. While AXIN1 is ubiquitously expressed, AXIN2 has more tissue-specific expression patterns and is notably upregulated by Wnt signaling, creating a negative feedback loop. AXIN2 has been implicated in neurodevelopment and neurodegenerative diseases.
.infobox.infix-protein
; Protein Name
: Axis Inhibition Protein 2
; Gene Symbol
: AXIN2
; UniProt ID
: Q9Y2T1
; PDB ID
: 1XM8
; Molecular Weight
: 88 kDa
; Subcellular Localization
: Cytoplasm, nucleus
; Protein Family
: Axin family
AXIN2 encodes an 843-amino acid protein that shares significant homology with AXIN1. Both proteins function as scaffolds for the beta-catenin destruction complex, but AXIN2 has distinct expression patterns and regulatory functions. AXIN2 is a direct target of Wnt/beta-catenin signaling, creating a negative feedback loop that modulates pathway activity[1].
Key features distinguishing AXIN2 include:
AXIN2 contains homologous domains to AXIN1:
AXIN2 plays roles in:
As a Wnt target gene, AXIN2 provides negative feedback:
AXIN2 dysfunction may contribute to AD through:
AXIN2 expression is altered in PD models:
Dysregulated AXIN2 has been implicated in:
| Protein | Interaction | Function |
|---|---|---|
| CTNNB1 | Direct binding | Beta-catenin degradation |
| APC | Direct binding | Destruction complex |
| GSK3β | Direct binding | Phosphorylation |
| β-catenin | Direct binding | Substrate |
Current research explores:
The study of Axin2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.